Methoxypolyethylene glycol epoetin beta
Term · Oncology and biomedicine · MLC-T-ONC-005324
A substance being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells) that has been changed in the laboratory. Also called Ro 50-3821.
| Identifier | MLC-T-ONC-005324 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Ro 50-3821 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005324",
"term": "Methoxypolyethylene glycol epoetin beta",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells) that has been changed in the laboratory. Also called Ro 50-3821.",
"synonyms": [
"Ro 50-3821"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/methoxypolyethylene-glycol-epoetin-beta/"
}
Record 10,943 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.